A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to...

Full description

Bibliographic Details
Main Authors: Tu Chih-Yen, Hsia Te-Chun, Fang Hsin-Yuan, Liang Ji-An, Yang Su-Tso, Li Chia-Chin, Chien Chun-Ru
Format: Article
Language:English
Published: Sciendo 2017-12-01
Series:Radiology and Oncology
Subjects:
stereotactic ablative radiotherapy
conventional fractionated radiotherapy
non-small cell lung cancer
Online Access:https://doi.org/10.1515/raon-2017-0058
id doaj-0c42da6f10db4329a4945c5e64fb93f8
record_format Article
spelling doaj-0c42da6f10db4329a4945c5e64fb93f82021-09-05T14:00:10ZengSciendoRadiology and Oncology1581-32072017-12-0152218118810.1515/raon-2017-0058raon-2017-0058A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patientsTu Chih-Yen0Hsia Te-Chun1Fang Hsin-Yuan2Liang Ji-An3Yang Su-Tso4Li Chia-Chin5Chien Chun-Ru6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, TaiwanDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, TaiwanDepartment of Chest Surgery, China Medical University Hospital, Taichung, TaiwanDepartment of Radiation Oncology, China Medical University Hospital, Taichung, TaiwanDepartment of Radiology, China Medical University Hospital, Taichung, TaiwanDepartment of Radiation Oncology, China Medical University Hospital, Taichung, TaiwanDepartment of Radiation Oncology, China Medical University Hospital, Taichung, TaiwanStereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC.https://doi.org/10.1515/raon-2017-0058stereotactic ablative radiotherapyconventional fractionated radiotherapynon-small cell lung cancer
collection DOAJ
language English
format Article
sources DOAJ
author Tu Chih-Yen
Hsia Te-Chun
Fang Hsin-Yuan
Liang Ji-An
Yang Su-Tso
Li Chia-Chin
Chien Chun-Ru
spellingShingle Tu Chih-Yen
Hsia Te-Chun
Fang Hsin-Yuan
Liang Ji-An
Yang Su-Tso
Li Chia-Chin
Chien Chun-Ru
A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
Radiology and Oncology
stereotactic ablative radiotherapy
conventional fractionated radiotherapy
non-small cell lung cancer
author_facet Tu Chih-Yen
Hsia Te-Chun
Fang Hsin-Yuan
Liang Ji-An
Yang Su-Tso
Li Chia-Chin
Chien Chun-Ru
author_sort Tu Chih-Yen
title A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
title_short A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
title_full A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
title_fullStr A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
title_full_unstemmed A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients
title_sort population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage i non-small cell lung cancer patients
publisher Sciendo
series Radiology and Oncology
issn 1581-3207
publishDate 2017-12-01
description Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC.
topic stereotactic ablative radiotherapy
conventional fractionated radiotherapy
non-small cell lung cancer
url https://doi.org/10.1515/raon-2017-0058
work_keys_str_mv AT tuchihyen apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT hsiatechun apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT fanghsinyuan apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT liangjian apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT yangsutso apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT lichiachin apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT chienchunru apopulationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT tuchihyen populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT hsiatechun populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT fanghsinyuan populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT liangjian populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT yangsutso populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT lichiachin populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
AT chienchunru populationbasedstudyoftheeffectivenessofstereotacticablativeradiotherapyversusconventionalfractionatedradiotherapyforclinicalstageinonsmallcelllungcancerpatients
_version_ 1717812423927267328

Similar Items